Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma

This article has no abstract
Epistemonikos ID: e605e63c22bac77539d0898ece5592f08ad5998b
First added on: Feb 14, 2025